Tower Research Capital LLC (Trc) Viatris Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Viatris Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,188 shares of VTRS stock, worth $204,100. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,188
Previous 31,488
35.89%
Holding current value
$204,100
Previous $274,000
34.31%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding VTRS
# of Institutions
1,128Shares Held
986MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$937 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$796 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$671 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$559 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...